Cargando…

Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients

Background: Sildenafil, a phosphodiestase type 5 inhibitor, was approved in 2005 for the treatment of pulmonary arterial hypertension (PAH) in adults and is commonly used off-label for pediatric patients. Little is known, however, about sildenafil’s side effects in this population. Methods: Single i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siehr, Stephanie L., McCarthy, Elisa K., Ogawa, Michelle T., Feinstein, Jeffrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353247/ https://www.ncbi.nlm.nih.gov/pubmed/25806361 http://dx.doi.org/10.3389/fped.2015.00012

Ejemplares similares

Central line replacement following infection does not improve reinfection rates in pediatric pulmonary hypertension patients receiving intravenous prostanoid therapy
por: McCarthy, Elisa K., et al.
Publicado: (2018)

Persistent Pulmonary Hypertension of the Newborn: The Efficacy Comparison of Vasodilators Sildenafil Plus Bosentan Versus Sildenafil Plus Beraprost at a Tertiary Childcare Health Facility
por: Adnan, Mudasser, et al.
Publicado: (2021)

Sildenafil in pediatric pulmonary arterial hypertension
por: Dhariwal, AK, et al.
Publicado: (2015)

Abnormal platelet aggregation in pediatric pulmonary hypertension
por: Handler, Stephanie S., et al.
Publicado: (2022)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
por: Wei, Enhuan, et al.
Publicado: (2023)

Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report
por: La Torre, Francesco, et al.
Publicado: (2023)

Editorial: Pediatric Pulmonary Hypertension
por: Beghetti, Maurice, et al.
Publicado: (2015)

Echocardiography in Pediatric Pulmonary Hypertension
por: Jone, Pei-Ni, et al.
Publicado: (2014)

Comparison between the Acute Pulmonary Vascular Effects of Oxygen with Nitric Oxide and Sildenafil
por: Day, Ronald W.
Publicado: (2015)

Sildenafil in the treatment of pulmonary hypertension
por: Barnett, Christopher F, et al.
Publicado: (2006)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
por: Faircloth, Jenna M., et al.
Publicado: (2023)

Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension
por: Blalock, Shannon, et al.
Publicado: (2013)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
por: Faircloth, Jenna M., et al.
Publicado: (2023)

Editorial: Advances in the care of the pediatric pulmonary hypertension patient: from the neonate to the adolescent-young adult patient
por: Avitabile, Catherine M., et al.
Publicado: (2023)

Skeletal muscle deficits are associated with worse exercise performance in pediatric pulmonary hypertension
por: Avitabile, Catherine M., et al.
Publicado: (2022)

Pharmacokinetic and Pharmacodynamic Comparison of Sildenafil‐Bosentan and Sildenafil‐Ambrisentan Combination Therapies for Pulmonary Hypertension
por: Hakamata, A, et al.
Publicado: (2016)

Biomarkers for Pediatric Pulmonary Arterial Hypertension – A Call to Collaborate
por: Colvin, Kelley L., et al.
Publicado: (2014)

Right ventricular stroke work correlates with outcomes in pediatric pulmonary arterial hypertension
por: Yang, Weiguang, et al.
Publicado: (2018)

Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease
por: Fukasawa, Yoshie, et al.
Publicado: (2023)

Bosentan for Treatment of Pediatric Idiopathic Pulmonary Arterial Hypertension: State-of-the-Art
por: Wang, Yuchen, et al.
Publicado: (2019)

Prevalence of malnutrition in pediatric pulmonary hypertension cohort and role for registered dietitian involvement
por: Crowell, Presley R., et al.
Publicado: (2023)

Hereditary pulmonary arterial hypertension burden in pediatrics: A single referral center experience
por: Ishizuka, Maki, et al.
Publicado: (2023)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Is Sildenafil an Effective Therapy in the Management of Persistent Pulmonary Hypertension?
por: Yaseen, Hakam, et al.
Publicado: (2012)

Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
por: Chinello, Pierangelo, et al.
Publicado: (2011)

Sildenafil in endotoxin-induced pulmonary hypertension: an experimental study
por: Kemper, Daniella Aparecida Godoi, et al.
Publicado: (2021)

Pediatric pulmonary actinomycosis: A misdiagnosed case report
por: Yilin, Zhao, et al.
Publicado: (2022)

Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021)

Hypertensive Crisis in Pediatric Patients: An Overview
por: Raina, Rupesh, et al.
Publicado: (2020)

Editorial: Pediatric Hypertension: Update
por: Shatat, Ibrahim F., et al.
Publicado: (2018)

A Canadian, retrospective, multicenter experience with selexipag for a heterogeneous group of pediatric pulmonary hypertension patients
por: Youssef, David, et al.
Publicado: (2023)

Pediatric Lupus Presenting as Pulmonary Hypertension, Myocarditis, and Massive Pericardial Effusion in an 11-Year-Old Girl: A Case Report and Literature Review
por: Chen, Yu-Jhen, et al.
Publicado: (2022)

Evaluation of right ventricular longitudinal strain in pediatric patients with pulmonary hypertension by two-dimensional speckle-tracking echocardiography
por: Liu, Qianjun, et al.
Publicado: (2023)

Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension
por: YOSHIYUKI, Rieko, et al.
Publicado: (2016)

Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
por: Keogh, Anne M, et al.
Publicado: (2008)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
por: Ramani, Gautam V, et al.
Publicado: (2010)

Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia
por: Lilyasari, Oktavia, et al.
Publicado: (2019)

Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis
por: van der Graaf, Marisa, et al.
Publicado: (2019)

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
por: Ghofrani, Hossein A., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_qshq7jhmq1g1mlbdojkqjg4e3h